Lilly hires new ACE president

Eli Lilly & Company veteran, Andrew Hotchkiss, is to become the company's president for the Australia, Canada and Europe (ACE) region.

Hotchkiss takes over from Karim Bitar, and will lead company activities across the region, as Lilly seeks to deliver innovative developments tackling illnesses such as diabetes, heart disease, mental health and cancer. 

Andrew Hotchkiss

Hotchkiss was most recently vice president and international business unit leader for Lilly Oncology.

"I am proud and excited to have the opportunity to lead Lilly's hugely talented pool of dedicated employees across the region, who are focused on the mission to help improve outcomes for patients," said Hotchkiss.

Bryce Carmine, executive vice president and president, Lilly Bio-Medicines, also commented on the appointment: "[Hotchkiss] will be a tremendous asset to the organisation in leading our efforts to maximise the value of our marketed products and prepare Lilly's ACE region for the next wave of innovative Lilly medicines."